Sunflower Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 3.6% in First Quarter of 2022

Sunflower Pharmaceutical Group Co.,Ltd. (葵花药业集团股份有限公司) (002737.SZ) reported a net profit of 234.3 million yuan in the first quarter of 2022, down 3.6% year-on-year.

Meanwhile, the company posted 1.2 billion yuan in revenue, down 1.5% year-on-year.

At the end of the reporting period, it had 5.7 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 27.5%.